GO:0070176 DRM complex: Components, Assembly and Research

The DRM complex (GO:0070176) is a conserved transcriptional repressor complex that contains the lin-9, lin-35, lin-37, lin-52, lin-53, lin-54, dpl-1 and efl-1 proteins and is involved in cell fate specification. It is also known by the synonym DP/Rb/MuvB, reflecting its functional relationship with the DP, retinoblastoma (Rb), and MuvB pathways. Understanding this complex is critical because it integrates cell cycle regulation with developmental gene expression programs, and its components are frequently studied in the context of cancer and differentiation. In Caenorhabditis elegans, the DRM complex was shown to bind chromosomes in a biased manner and to regulate gene expression, providing a paradigm for how this repressor module controls cell fate decisions. The complex acts as a platform for transcriptional repression, and its subunits are conserved across metazoans, making it a valuable model for studying fundamental mechanisms of gene regulation. Researchers investigating cell fate specification, transcriptional repression, and cancer biology often focus on the DRM complex because perturbations in its components can lead to developmental defects and disease. This article summarizes the current knowledge of the DRM complex based on authoritative QuickGO data and verified PubMed literature, and outlines experimental strategies for its study.

The DRM complex is a cellular component defined as a transcriptional repressor complex that contains the lin-9, lin-35, lin-37, lin-52, lin-53, lin-54, dpl-1 and efl-1 proteins, and is involved in cell fate specification. It is synonymous with the DP/Rb/MuvB complex, highlighting its evolutionary conservation and functional association with the DP, Rb, and MuvB pathways.

The DRM complex is important because it serves as a conserved transcriptional repressor that links cell cycle control to developmental gene expression, and its dysfunction can disrupt cell fate specification and contribute to cancer. Studying the DRM complex helps researchers understand how repressive complexes coordinate gene expression programs during development and how their misregulation leads to disease.

The DRM complex comprises eight core proteins that are conserved and have been experimentally characterized in Caenorhabditis elegans.

The DRM complex is regulated at multiple levels, including subunit availability and post-translational modifications. Its assembly and activity are coordinated with the cell cycle, and it interacts with the DP/Rb/MuvB pathway to repress target genes. The complex binds chromosomes in a biased manner, suggesting that chromatin context and DNA sequence influence its recruitment and repressive activity.

Components of the DRM complex, such as LIN-35 (the Caenorhabditis elegans ortholog of Rb), are linked to tumor suppressor pathways. Dysregulation of the DP/Rb/MuvB pathway, with which the DRM complex is synonymous, can lead to uncontrolled cell proliferation and cancer. Studying the DRM complex provides insights into how transcriptional repression prevents tumorigenesis.

The DRM complex is involved in cell fate specification, and its dysfunction can cause developmental defects. Mutations in DRM complex subunits in model organisms lead to abnormal cell fate decisions, highlighting its importance in development.

Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is used to map the binding sites of DRM complex subunits across the genome. This method revealed that the DRM complex binds chromosomes in a biased manner and identified target regions. ChIP-seq is essential for understanding how the complex recognizes and represses specific genes.

RNA sequencing (RNA-seq) is employed to measure changes in gene expression upon loss or gain of DRM complex function. By comparing wild-type and mutant transcriptomes, researchers can identify genes repressed by the DRM complex. This approach has been used to demonstrate the complex's role in gene regulation.

Affinity purification coupled with mass spectrometry (AP-MS) is used to identify the protein components of the DRM complex and its interacting partners. This method confirmed the presence of LIN-9, LIN-35, LIN-37, LIN-52, LIN-53, LIN-54, DPL-1, and EFL-1 in the complex. Proteomics also helps uncover post-translational modifications and dynamic interactions.

Targeted gene knockouts or RNAi-mediated knockdowns of DRM complex subunits are used to study loss-of-function phenotypes. These experiments have shown that the complex is required for cell fate specification and proper development. Knockout models are valuable for dissecting the specific roles of each subunit.

Researchers studying DRM complex-related genes often need to determine whether a candidate gene is causally involved in transcriptional repression and cell fate specification. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models for such investigations.

The DRM complex (GO:0070176) is a conserved transcriptional repressor complex that plays a critical role in cell fate specification and gene regulation. Its eight core subunits, including LIN-9, LIN-35, LIN-37, LIN-52, LIN-53, LIN-54, DPL-1, and EFL-1, form a functional unit that binds chromosomes and represses target genes. Understanding the DRM complex provides insights into developmental biology and cancer, and ongoing research using CRISPR models continues to unravel its mechanisms. EDITGENE offers a full range of CRISPR services to support DRM complex research, from knockout and knock-in models to library screening and bioinformatics, enabling researchers to accelerate their discoveries.